Aurobindo Pharma
-
Aurobindo Pharma posts consolidated net profit of Rs 2,946.32 crore in Dec quarter
The consolidated revenue from operations of the company stood at Rs 6,364.91 crore Drug firm Aurobindo Pharma reported an over…
Read More » -
Aurobindo Pharma, KAPL get nod under PLI scheme
Manufacturing bulk drugs will be promoted The government has approved drug firms including Aurobindo Pharma and Karnataka Antibiotics & Pharmaceuticals…
Read More » -
Aurobindo Pharma in agreement with COVAXX
To develop and commercialise COVID-19 vaccine UB-612 for India and UNICEF Aurobindo Pharma and COVAXX, a US-based company, have entered…
Read More » -
US FDA approves Aurobindo Pharma’s sedative drug
According to the company, the product will be launched in January 2021 Aurobindo Pharma has received final approval from the…
Read More » -
Aurobindo Pharma expects to commercialise vaccine facility by April-May
The Hyderabad-based drug major is investing around Rs 275 crore on the facility Aurobindo Pharma expects to commercialise its vaccine…
Read More » -
Pfizer moves US court against Aurobindo Pharma, Dr Reddy’s
According to Pfizer, the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion…
Read More » -
Drug firms recall various products in US market
Markson’s Pharma, Zydus Pharmaceuticals, Aurobindo Pharma and Jubilant Cadista are all recalling products India-based drug firms like Marksans Pharma, Aurobindo…
Read More » -
New Mountain in agreement with Aurobindo Pharma
To acquire Natrol from Aurobindo Pharma New Mountain Capital announced that it has reached a definitive agreement with Aurobindo Pharma…
Read More » -
CCMB-Hyd partners with Aurobindo Pharma
CCMB-Hyderabad, IMTECH in Chandigarh and IICB in Kolkata are developing vaccine candidates using different technology platforms The Council of Scientific…
Read More »